Supriya Peshin: Key Trials and Future Clinical Applications of Immunotherapy in GI Cancers
Supriya Peshin, Internal Medicine Resident Physician at Ballad Health, shared a post on LinkedIn about a paper she co-authored with colleagues published in Antibodies:
“Publication Alert! Kudos to the team effort.
Immunotherapy has revolutionized treatment in gastrointestinal cancers, with immune checkpoint inhibitors showing remarkable efficacy in dMMR/MSI-H colorectal cancer and select esophagogastric and liver tumors. However, challenges such as resistance, limited efficacy in pMMR tumors, and tumor heterogeneity underscore the need for biomarker-driven, precision-based strategies.”
Title: Immunotherapy in GI Cancers: Lessons from Key Trials and Future Clinical Applications
Authors: Supriya Peshin, Faizan Bashir, Naga Anvesh Kodali, Adit Dharia, Sajida Zaiter, Sakshi Singal, Nagaishwarya Moka
You can read the Full Article in Antibodies.
More posts featuring Supriya Peshin.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023